Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 486-070-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 06 December 2006 to 25 January 2008
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study was performed according to international test guidelines and to GLP.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 008
- Report date:
- 2008
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- yes
- Remarks:
- The relative humidity ranged between 25 - 72% instead of between 30 - 70%. However, this deviation did not affect the validity of the experiment.
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- yes
- Remarks:
- The relative humidity ranged between 25 - 72% instead of between 30 - 70%. However, this deviation did not affect the validity of the experiment.
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- micronucleus assay
Test material
- Test material form:
- other: liquid
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Winkelmann GmbH, D-33178 Borchen, Germany
- Age at study initiation: 8 to 10 weeks
- Weight at study initiation: males: 36.2 +/- 1.3 g; females: 28.6 +/- 1.6g
- Assigned to test groups randomly: yes
- Fasting period before study: no
- Housing: Individually in Makrolon Type I cages, with wire mesh top (EHRET GmbH, D-79302 Emmendingen) and granulated soft wood bedding (Harlan Winkelmann GmbH, D-33178 Borchen).
- Diet: pelleted standard diet (Harlan Winkelmann GmbH, D-33178 Borchen), ad libitum.
- Water: tap water (Gemeindewerke, D-64380 Roßdorf), ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C):22 +/- 3 °C
- Humidity (%): 25 - 72 %
- Air changes (per hr): information not available.
- Photoperiod (hrs dark / hrs light): 12/12.
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- - Vehicle used: corn oil
- Justification for choice of vehicle: The vehicle was chosen to its relative non-toxicity for the animals. - Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
Volume administered: 10 mL/kg body weight - Duration of treatment / exposure:
- one single intraperitoneal injection
- Frequency of treatment:
- one single intraperitoneal injection
- Post exposure period:
- The animals of all dose groups were examined for acute toxic symptoms at intervals of around 1 h, 2 - 4 h, 6 h, 24 and 48 h after administration of the test item and sacrificed 24 or 48 hours after treatment.
Doses / concentrations
- Remarks:
- Doses / Concentrations:
375, 750, 1500 mg/kg bw
Basis:
nominal conc.
- No. of animals per sex per dose:
- 6 animals/sex/dose/sacrifice time
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- yes: CPA (Cyclophosphamide)
- Justification for choice of positive control: reference mutagen
- Route of administration: intraperitoneal injection, once
- Dose: 40 mg/kg b.w.
Examinations
- Tissues and cell types examined:
- see details below.
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
It is generally recommended to use the maximum tolerated dose or the highest dose that can be formulated and administered reproducibly or 2000 mg/kg as the upper limit for non-toxic test items. The maximum tolerated dose level is determined to be the dose that causes toxic reactions without having major effects on survival within 48 hours.
In the current study, a preliminary study on acute toxicity was performed with two animals per sex under identical conditions as in the mutagenicity study concerning: animal strain, vehicle, route, frequency, and volume of administration. The animals were treated i.p. with the test item (at doses ranging from 100 to 2000 mg/kg) and examined for acute toxic symptoms at intervals of around 1 h, 2-4 h, 6 h, 24 h, 30 h, and 48 h after administration of the test item.
Based on the preliminary study, the dose levels of 375, 750 and 1500 mg/kg were selected for the main experiment.
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields):
The animals received the test item, the vehicle or the positive control substance once. They were examined for toxic symptoms at regular intervals after administration (see details above) and were sacrificed 24 (375, 750 and 1500 mg/kg dose groups) or 48 hours (additional 1500 mg/kg dose group) after treatment. Sampling of the bone marrow was done at necrospy.
DETAILS OF SLIDE PREPARATION:
The animals were sacrificed using CO2 followed by bleeding. The femora were removed, the epiphyses were cut off and the marrow was flushed out with foetal calf serum using a syringe. The cell suspension was centrifuged at 1500 rpm (390 x g) for 10 minutes and the supernatant was discarded. A small drop of the re-suspended cell pellet was spread on a slide. The smear was air-dried and then stained with May-Grünwald (Merck, D-64293 Darmstadt)/Giemsa (Merck, D-64293 Darmstadt). Cover slips were mounted with EUKITT (Kindler, D-79110 Freiburg). At least one slide was made from each bone marrow sample.
METHOD OF ANALYSIS:
Evaluation of the slides was performed using NIKON microscopes with 100x oil immersion objectives. At least 2000 polychromatic erythrocytes (PCE) were analysed per animal for micronuclei*. To describe a cytotoxic effect the ratio between polychromatic and normochromatic erythrocytes was determined in the same sample and expressed in polychromatic erythrocytes per 2000 erythrocytes. The analysis was performed with coded slides.
Ten animals (5 males, 5 females) per test group were evaluated as described, the remaining 6th animal of each sex in the respective test group test group being usually evaluated in case an animal dies in its test group spontaneously.
* Originally only 2000 PCEs were scored. However, in order to confirm the obtained data, the number of PCEs to be scored was increased to 6000. - Evaluation criteria:
- Acceptance criteria:
The study was considered valid as the following criteria are met:
- the negative controls are in the range of the laboratory historical control data.
- the positive controls are in the range of the laboratory historical control data.
- at least 4 animals per group and sex can be evaluated.
- PCE to erythrocyte ratio should not be less than 20 % of the negative control.
Evaluation of results:
- A test item is classified as mutagenic if it induces either a dose-related increase or a clear increase in the number of micronucleated polychromatic erythrocytes in a single dose group.
- A test item that fails to produce a biological relevant increase in the number of micronucleated polychromatic erythrocytes is considered non-mutagenic in this system. - Statistics:
- nonparametric Mann-Whitney test
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- ambiguous
- Remarks:
- see details below
- Toxicity:
- yes
- Remarks:
- see details below
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- Doses producing toxicity:
A pre-study was conducted with 2 mice per sex per dose to determine the Maximum Tolerated Dose. Doses of 100, 1000, 2000, 1500 and 1750 mg/kg b.w. i.p. were consecutively tested. The maximum tolerated dose was determined to be 1500 mg/kg for i.p. administration in mice (animals expressed toxic reactions but without mortality) and was thus considered to be suitable for the main experiment. Higher doses induced mortality (1 male and 1 female at 48 hrs at 1750 mg/kg, and 2 males and 2 females within 2 hrs at 2000 mg/kg).
Results from the main experiment:
During the main experiment, the main clinical signs observed following treatment were reduction of spontaneous activity (all animals in the high
dose group), abdominal position (only in some animals of the high dose group), eyelid closure and ruffled fur.
The mean number of PCE per 2000 erythrocytes was slightly decreased after treatment with the high dose as compared to the mean value in the vehicle control group, showing some cytoxicity in the bone marrow cells:
- vehicle control, 24 h: 1115
- 375 mg/kg, 24 h: 1069
- 750 mg/kg, 24 h: 1076
- 1500 mg/kg, 24 h: 935
- positive control (CPA), 24h: 1130
- 1500 mg/kg, 48 h: 1071
In comparison to the vehicle control group (0.115% of PCE with micronuclei), there was a dose-dependent increase in the frequency of the detected micronuclei (0.145%, 0.160%, and 0.210%) after administration of the notified substance. The increase was statistically significant only at 1500 mg/kg dose. The increase at that dose also exceeded the upper limit of the historical control range (0.16%).
The positive control group (40 mg/kg ip cyclophosphamide) showed a statistically significant increase of induced micronucleus frequency (2.68%).
Results of the vehicle control group were within the historical control ranges.
Due to the slight but statistically significant increase of PCEs with micronuclei at the highest dose, the result of this test is considered equivocal.
Any other information on results incl. tables
Summary of Micronucleus Test Results:
test group |
dose (mg/kg b.w.) |
sampling time (h) |
PCEs with micronuclei (%) |
range |
PCE per 2000 erythocytes |
vehicle |
0 |
24 |
0.115 |
1 -4 |
1115 |
test item |
375 |
24 |
0.145 |
2 - 4 |
1069 |
750 |
24 |
0.160 |
1 - 6 |
1076 |
|
1500 |
24 |
0.210* |
2 - 9 |
935 |
|
1500 |
48 |
0.095 |
0 - 4 |
1071 |
|
Positive control |
40 |
24 |
2.680* |
23 - 81 |
1130 |
* : p < 0.05
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): ambiguous
Under the experimental conditions, the results of this study performed with Dimethyl 2-methyl glutarate are inconclusive. - Executive summary:
This study was performed to investigate the potential of Dimethyl 2 -methyl glutarate to induce micronuclei in polychromatic erythrocytes (PCE) in the bone marrow of the mouse.
The test item was formulated in corn oil, which was also used as vehicle control. The volume administered intraperitoneally (i.p.) was 10 mL/kg b.w.. Twenty four and 48 h after a single administration of the test item the bone marrow cells were collected for micronuclei analysis.
Ten animals (5 males, 5 females) per test group were evaluated for the occurrence of micronuclei. 6000 polychromatic erythrocytes (PCEs) per animal were scored for micronuclei.
To describe a cytotoxic effect due to the treatment with the test item the ratio between polychromatic and normochromatic erythrocytes was determined in the same sample and reported as the number of PCEs per 2000 erythrocytes.
The following dose levels of the test item were investigated:
24 h preparation interval: 375, 750, and 1500 mg/kg b.w..
48 h preparation interval: 1500 mg/kg b.w..The highest dose (1500 mg/kg) was estimated by pre-experiments to be suitable.
After treatment with the test item the number of PCEs was slightly decreased as compared to the mean value of PCEs of the vehicle control thus indicating that the test item exerted slight cytotoxic effects in the bone marrow.
In comparison to the corresponding vehicle controls there was a statistically significant enhancement in the frequency of the detected micronuclei after administration of the test item. This enhancement, however, could not be reproduced in follow up studies. Therefore, the biological relevance of the observed effect is questionable.
40 mg/kg b.w. cyclophosphamide administered i.p. was used as positive control which showed a substantial increase of induced micronucleus frequency.
In conclusion, it can be stated that under the experimental conditions reported, the results of this study performed with Dimethyl 2-methyl glutarate are inconclusive.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Although ECHA is providing a lot of online material in your language, part of this page is only in English. More about ECHA’s multilingual practice.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
the-echa-website-uses-cookies
find-out-more-on how-we-use-cookies